To validate GJB2 as an inhibitor of HIV-1 infection, we isolated total CD4+ T cells from four people living with HIV (PLWH) whose viral loads were undetected (see Table S1 for their background data) and stimulated their CD4+ T cells transduced with lentiviral expression vectors (Fig. S5A). This evidence concerns the gene CD4 and HIV-1 infection.